• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, October 28, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

Immune cells in the gut act as an unexpected shield against inflammation

by
October 28, 2026
in Biology
Reading Time: 2 mins read
0
Immune cells in the gut act as an unexpected shield against inflammation

Immune cells in the gut act as an unexpected shield against inflammation

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Follicular helper T (TFH) cells, long known for helping B cells produce antibodies, also play a surprising role in keeping the immune system calm in the gut, according to a study published in Nature Immunology on 21 October 2026. Shivangi Dave, Holly Bachus and colleagues in André Ballesteros-Tato’s laboratory report that a subset of TFH cells produces interleukin-2 (IL-2), a key immune signalling molecule, at the border between T cells and B cells and within interfollicular regions of gut-associated lymphoid tissues (GALT). This locally delivered IL-2 appears essential for maintaining the population of regulatory T (Treg) cells, the immune cells that suppress inappropriate immune responses.

Using mouse models in which IL-2-producing TFH cells were selectively depleted or genetically ablated, the researchers found that GALT Treg cell maintenance was disrupted and effector T cell activation became uncontrolled. Mice lacking this IL-2 supply developed colitis and fatal multiorgan inflammation. The team’s figures trace this progression step by step: TFH cells and Treg cells share niches in the GALT, TFH cell deficiency destabilises Treg cell maintenance, and the balance of Treg cell subsets shifts from a protective to a pathogenic state when TFH cell-derived IL-2 is absent.

A striking clue to the mechanism came from antibiotic treatment. When mice lacking IL-2-producing TFH cells were given broad-spectrum antibiotics, both intestinal and extraintestinal pathology were alleviated. The authors interpret this as evidence that loss of tolerance to commensal-derived antigens, the microbes that normally live harmlessly in the gut, is a key driver of the disease observed in these animals. In other words, without the local IL-2 niche, the immune system loses its ability to remain tolerant to the gut’s resident microbial community, and the resulting inflammatory response spills beyond the intestine.

Importantly, the study shows that this TFH cell function is independent of B cells, distinguishing it from the cells’ well-characterised role in supporting antibody responses. The findings define what the authors call a spatially restricted TFH cell-derived IL-2 niche that is critical for Treg cell stability in gut-associated lymphoid tissues and reveal an immunoregulatory role for TFH cells in maintaining gastrointestinal tolerance. The work was conducted in mice, so its implications for human intestinal immunity and inflammatory disease remain to be established. The full study is available behind a subscription paywall at Nature Immunology, with the abstract and figure summaries publicly accessible.

Subject of Research: The role of IL-2-producing follicular helper T cells in maintaining regulatory T cell homeostasis and immune tolerance in gut-associated lymphoid tissues.

Article Title: IL-2-producing TFH cells sustain Treg cell homeostasis and immune tolerance in the gut

Article References: Dave, S., Bachus, H., Santiago, N., Meloun, A., Smelkinson, M., Foote, J. B., Hill, T., Fucile, C., Rosenberg, A. F., & Ballesteros-Tato, A. (2026). IL-2-producing TFH cells sustain Treg cell homeostasis and immune tolerance in the gut. Nature Immunology, 27(11), 2267-2279. https://doi.org/10.1038/s41590-026-02690-5

Image Credits: AI Generated

DOI: 10.1038/s41590-026-02690-5

Keywords: TFH cells, IL-2, regulatory T cells, gut-associated lymphoid tissues, immune tolerance, colitis, commensal microbes, T cell–B cell border, multiorgan inflammation, Nature Immunology, mouse models, immunology

News Source: Kristina Jarvis. (October 28, 2026). Immune cells in the gut act as an unexpected shield against inflammation. Scienmag.

Tags: colitiscommensal microbesgut-associated lymphoid tissuesIL-2immune toleranceimmunologymouse modelsmultiorgan inflammationNature Immunologyregulatory T cellsT cell–B cell borderTFH cells
Share12Tweet7Share2ShareShareShare1

Related Posts

Laboratory Generations of Sugarcane Parasitoid Wasp Lose Fitness Within Ten Generations

Laboratory Generations of Sugarcane Parasitoid Wasp Lose Fitness Within Ten Generations

October 28, 2026
Prophages Shape Virulence, Not Resistance, in Staphylococcus aureus Genomes

Prophages Shape Virulence, Not Resistance, in Staphylococcus aureus Genomes

October 28, 2026

TREX1 enzyme shields tumors by destroying immune-activating DNA fragments

October 28, 2026

Evolutionary Feature Optimization Sharpens Latent Learning in Endoscopy Images

October 28, 2026

POPULAR NEWS

  • Systematic review maps end-of-life psychosocial and spiritual needs in physical disability

    Systematic review maps end-of-life psychosocial and spiritual needs in physical disability

    29 shares
    Share 12 Tweet 7
  • Text Message Campaign Reached Only a Third of Patients Overdue for Colorectal Cancer Screening

    29 shares
    Share 12 Tweet 7
  • FOXO1 Emerges as Candidate Regulator and Biomarker in Hip Dysplasia

    29 shares
    Share 12 Tweet 7
  • Regulators, developers and clinicians in Shenzhen voice concerns over medical AI governance

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Systematic review maps end-of-life psychosocial and spiritual needs in physical disability

Text Message Campaign Reached Only a Third of Patients Overdue for Colorectal Cancer Screening

FOXO1 Emerges as Candidate Regulator and Biomarker in Hip Dysplasia

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 85 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.